Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study

BACKGROUND: Treatment for HER2-positive (+) metastatic breast cancer has improved in the last decade. We analyzed treatment changes over time and their impact on patients outcomes in a real-world dataset. METHODS: Data from 637 HER2+ patients with metastatic breast cancer enrolled in the multicenter...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Maio, Massimo, Bighin, Claudia, Schettini, Francesco, Ruelle, Tommaso, Marandino, Laura, Fabi, Alessandra, De Angelis, Carmine, Giuliano, Mario, De Placido, Pietro, De Laurentiis, Michelino, Riccardi, Ferdinando, Picotto, Caterina, Puglisi, Fabio, Del Mastro, Lucia, Arpino, Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551556/
https://www.ncbi.nlm.nih.gov/pubmed/37783133
http://dx.doi.org/10.1016/j.breast.2023.103583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551556/
https://www.ncbi.nlm.nih.gov/pubmed/37783133
http://dx.doi.org/10.1016/j.breast.2023.103583

Ejemplares similares